Keyphrases
Tumor
100%
Molecular Pathways
100%
Synchronous Colorectal Cancer
100%
Microsatellite Instability-high (MSI-H)
91%
MLH1
58%
Microsatellite Stable
41%
MSH2
25%
Colorectal Carcinoma
16%
Synchronous Colorectal Carcinoma
16%
Malignancy
8%
Immunohistochemistry
8%
Methylation
8%
Family History
8%
Delayed Diagnosis
8%
Promoter Methylation
8%
Polymerase Chain Reaction Assay
8%
Chi-square Test
8%
MLH1 Gene
8%
Student's T-test
8%
Gene Promoter
8%
Statistical Comparison
8%
Amsterdam II Criteria
8%
Stable Distribution
8%
Polymerase Chain Reaction Amplification
8%
Methylation-specific Polymerase Chain Reaction
8%
Colon Adenocarcinoma
8%
Proportion of Tumour
8%
Sporadic CRC
8%
Hereditary Nonpolyposis
8%
Synchronous Tumors
8%
MLH1 Methylation
8%
Stable Status
8%
Medicine and Dentistry
Neoplasm
100%
Colorectal Carcinoma
100%
Microsatellite Instability
78%
Methylation
28%
Promoter Region
21%
Polymerase Chain Reaction
14%
Cancer
7%
Family History
7%
Immunohistochemistry
7%
Student T Test
7%
Chi Square Test
7%
Gene Promoter
7%
Colon Carcinoma
7%
Biochemistry, Genetics and Molecular Biology
Microsatellite Instability
100%
MLH1
81%
Microsatellite
45%
Methylation
36%
MSH2
27%
Promoter Region
27%
Polymerase Chain Reaction
18%
Colon
9%
Chi-Square Testing
9%
Student's t-Test
9%
Gene Promoter
9%
Neuroscience
Microsatellite Instability
100%
Microsatellite
45%
Promoter Region
36%
Methylation
36%
MSH2
27%
Polymerase Chain Reaction
18%
Immunohistochemistry
9%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Neoplasm
100%
Colon Carcinoma
7%